Scientists have identified a promising strategy to improve liver cancer immunotherapy: targeting B-cells. While immunotherapy has transformed cancer treatment by activating T-cells-a type of immune cell that fights cancerous cells-many patients still fail to respond. New research shows that B-cells-another type of immune cell that fights infections-may play a surprising role in limiting immunotherapy's effectiveness.
Source: Medical Xpress